ArticleJournal of cancer research and clinical oncology2021

Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial).

Andreas Boehle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.